Blockade of autoreceptor-mediated inhibition of norepinephrine release by atipamezole is maintained after chronic reuptake inhibition

This publication has 16 references indexed in Scilit:

• Autoreceptor‐mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment
  Journal of Neurochemistry, 2004
• How does pindolol improve antidepressant action?
  Trends in Pharmacological Sciences, 2001
• Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic α 2 -adrenoceptors
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2001
• Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. In vivo electrophysiological studies in the rat
  Neuropharmacology, 2000
• Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors
  International Journal of Neuropsychopharmacology, 2000
• Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of α2-adrenoceptor blockade
  Biological Psychiatry, 1999
• Actions of α2 adrenoceptor ligands at α2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for α2A adrenoceptors
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1998
• Facilitation of cognitive functions by a specific α2-adrenoceptor antagonist, atipamezole
  European Journal of Pharmacology, 1998
• Current advances and trends in the treatment of depression
  Trends in Pharmacological Sciences, 1994
• EFFECT OF CHRONIC TREATMENT WITH TRICYCLIC ANTIDEPRESSANT DRUGS ON IDENTIFIED BRAIN NORADRENERGIC AND SEROTONERGIC NEURONS
  Acta Psychiatrica Scandinavica, 1980